We earned the highest rating from SMERA for SMEs. We successfully completed a rigorous nine-month due diligence process by a global MNC, which selected us as their entry vehicle into the Indian market. Our relentless pursuit of excellence has led us to take multiple group entities to the capital markets with listings on the BSE and NSE emerge. Global private equity investments into our pharmaceutical group company strengthened the segment. We successfully implemented our blueprint to migrate to the main board and unlocked significant value with our exit.

Our strategic transformation has recalibrated our vision for growth through the private equity model, resulting in a remarkable presence in the capital markets with SME IPOs. We are committed to integrating our social vision with long-term wealth creation, evidenced by our pilot investments in multiple start-ups and solidifying private equity for growth capital. Additionally, we introduced a Debt to Capital Model for companies that were previously ineligible for direct investments, showcasing our adaptability and commitment to empowering SME businesses. As we continue to navigate the complexities of the investment landscape, we remain dedicated to creating lasting value for our the companies, the promoters, our investors, the government and all our stakeholders.